Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Preparation method and application of a thiolated polysaccharide-based hydrogel capable of in-situ injection molding and its drug carrier

An in situ injection and sulfhydrylation technology, applied in the field of tissue engineering, can solve the problems of poor recovery of injectable hydrogels, uncomfortable surgical operations, poor mechanical strength, etc., to promote skin wound healing, promote epithelial cell growth, and low cost. Effect

Active Publication Date: 2021-07-27
JINAN UNIVERSITY
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Currently, the most commonly used methods for preparing injectable hydrogels are UV light-induced crosslinking or the introduction of chemical crosslinking agents, but ultraviolet light crosslinking (photoinitiators) or the introduction of chemical crosslinking agents will have certain effects on cells. Potential toxic effects, while physically cross-linked injectable hydrogels have poor recovery and poor mechanical strength, making them unsuitable for surgical operations
Patent application numbers 200710058737.9 and 200710058738.3 both disclose thiolated chitosan hydrogel and its preparation method, but do not add any cross-linking agent and catalyst, and only use the oxidation of air to cross-link the disulfide bonds formed by the reaction between sulfhydryl groups Hydrogel, long time required

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of a thiolated polysaccharide-based hydrogel capable of in-situ injection molding and its drug carrier
  • Preparation method and application of a thiolated polysaccharide-based hydrogel capable of in-situ injection molding and its drug carrier
  • Preparation method and application of a thiolated polysaccharide-based hydrogel capable of in-situ injection molding and its drug carrier

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] (1) Weigh 1g of chitosan and dissolve it in 100mL of 0.5% (v / v) acetic acid aqueous solution, add 0.9586g of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiethylene Amine hydrochloride (EDAC) and 0.5754g of N-hydroxysuccinimide (NHS), stirred at room temperature for 15 minutes in the dark;

[0054] (2) Add cysteine ​​(the molar ratio of chitosan:cysteine ​​is 3:1) to the reaction system of step (1), add 1mol / L NaOH solution to adjust the system PH=5, room temperature, dark Stir the reaction for 5 hours; sequentially use HCl solution with pH=5.0, HCl solution with pH=5.0 containing 1% (w / v) NaCl and HCl solution with pH=5.0 as the dialysate, each in the dark for 1 day, and dialyze for 3 days in total. day, and finally freeze-dried to obtain the thiolated chitosan (CSSH) sample, which was preserved at 4°C;

[0055] (3) Add the thiolated chitosan prepared in step (2) into deionized water with pH = 8, fully dissolve it under magnetic stirring, put it into a refrigerator at -20°C...

Embodiment 2

[0058] (1) Weigh 1g of chitosan and dissolve it in 100mL of 0.5% (v / v) acetic acid aqueous solution, add 0.9586g of 1-ethyl-3-(3-dimethylaminopropyl)-dicarbonate Imine hydrochloride (EDAC) and 0.5754g of N-hydroxysuccinimide (NHS), stirred at room temperature for 15 minutes in the dark;

[0059] (2) Add cysteine ​​(the molar ratio of chitosan: cysteine ​​is 1:1) to the reaction system of step (1), add 1mol / L NaOH solution to adjust the system PH=5, room temperature, dark Stir the reaction for 5 hours; sequentially use HCl solution with pH=5.0, HCl solution with pH=5.0 containing 1% (w / v) NaCl and HCl solution with pH=5.0 as the dialysate, each in the dark for 1 day, and dialyze for 3 days in total. day, and finally freeze-dried to obtain the thiolated chitosan (CSSH) sample, which was preserved at 4°C;

[0060] (3) Add the thiolated chitosan prepared in step (2) into deionized water with pH = 8, fully dissolve it under magnetic stirring, put it into a refrigerator at -20°C fo...

Embodiment 3

[0063] (1) Weigh 1g of chitosan and dissolve it in 100mL of 0.5% (v / v) acetic acid aqueous solution, add 0.9586g of 1-ethyl-3-(3-dimethylaminopropyl)-dicarbonate Imine hydrochloride (EDAC) and 0.5754g of N-hydroxysuccinimide (NHS), stirred at room temperature for 15 minutes in the dark;

[0064] (2) Add cysteine ​​(the molar ratio of chitosan: cysteine ​​is 1:3) to the reaction system of step (1), add 1mol / L NaOH solution to adjust the pH of the system to 5, room temperature, dark Stir the reaction for 5 hours; sequentially use HCl solution with pH=5.0, HCl solution with pH=5.0 containing 1% (w / v) NaCl and HCl solution with pH=5.0 as the dialysate, each in the dark for 1 day, and dialyze for 3 days in total. day, and finally freeze-dried to obtain a thiolated chitosan (CSSH) sample, which was stored at 4°C;

[0065] (3) Add the thiolated chitosan prepared in step (2) into deionized water with pH = 8, fully dissolve it under magnetic stirring, put it into a refrigerator at -20...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of tissue engineering scaffolds, and discloses a preparation method and application of a thiolated polysaccharide-based hydrogel capable of in-situ injection molding and a drug carrier thereof. The thiolated polysaccharide-based hydrogel is composed of 3% to 6% (w / v) thiolated polysaccharide and 10%-29% (w / v) sodium β-glycerophosphate form a thiolated polysaccharide-based hydrogel that can be molded in situ, in which the thiolated polysaccharide can be coated One or more of drug-loaded liposomes, drug-loaded thiol halloysite or polypeptides form a thiol-polysaccharide-based hydrogel drug carrier that can be molded in situ. The mercapto-polysaccharide-based hydrogel capable of in-situ injection molding and its drug carrier can realize gelation under human physiological temperature conditions, and have temperature sensitivity, injectability and water absorption.

Description

technical field [0001] The invention belongs to the field of tissue engineering, and in particular relates to a preparation method and application of a thiolated polysaccharide-based hydrogel capable of in-situ injection molding and a drug carrier thereof. Background technique [0002] The skin is an important part of the human body. It is in direct contact with the outside world and is vulnerable to various traumas, such as burns, scratches, infections, tumor resections, and skin ulcers caused by diabetes. The resection and recurrence of bone tumors will increase the pain of the patient in the second operation. Anti-tumor drugs can be entrapped in the gel, which can fill the defect and prevent tumor recurrence. The release of the drug can be controlled by the entrapment of the drug, and the side effects of the tumor drug can be reduced. It has a certain application prospect. [0003] Natural polysaccharide materials such as sodium alginate, hyaluronic acid, chitosan and ot...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/715A61L27/20A61L27/52A61L27/54
CPCA61L27/20A61L27/52A61L27/54A61L2300/216A61L2300/412A61L2300/416A61L2400/06C08L5/04C08L5/08
Inventor 李立华李日旺林振
Owner JINAN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com